Previous studies have shown that clinicopathological parameters and survivin levels are directly related, whereas other studies have produced contradictory results.[49–51] In patients with pancreatic cancer, the serum survivin level is not known to be correlated with age, sex, or tumor size.[43]. Here, BIRC5 is linked to pancreatic neoplasm.